Platelets in chronic liver disease, from bench to bedside

被引:53
|
作者
Ramadori, Pierluigi [1 ]
Klag, Thomas [2 ]
Malek, Nisar Peter [2 ]
Heikenwalder, Mathias [1 ]
机构
[1] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[2] Univ Tubingen, Dept Internal Med 1, Muller Str 10, D-72076 Tubingen, Germany
关键词
Platelets; cirrhosis; HCC; cancer; immune system; immunology; NASH; NAFLD; LOW-DOSE ASPIRIN; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL; HCV INFECTION; KUPFFER CELLS; DRUG-THERAPY; MOUSE MODEL; LIFE-SPAN;
D O I
10.1016/j.jhepr.2019.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the last decade, numerous studies revealed physiologic and pathophysiologic roles of platelets beyond haemostasis, a process to prevent and stop bleeding. These include the activation of the immune system and the promotion of inflammation, infection and cancer. Hence, the emerging view on the role of platelets has shifted - platelets are nowseen as alert "sentinels" of the immune compartment, rather than passive bystanders. Herein, we review well-established and newly discovered features of platelets that define their natural role in maintaining blood haemostasis, but also their functional relationship with other cells of the immune system. We focus on recent studies underlining functional involvement of platelets in chronic liver diseases and cancer, as well as the effects of anti-platelet therapy in these contexts. Finally, we illustrate the potential of platelets as possible diagnostic and therapeutic tools in liver disease based on recently developed methodologies. (c) 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:448 / 459
页数:12
相关论文
共 50 条
  • [1] Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back
    Yilmaz, Yusuf
    Colak, Yasar
    Kurt, Ramazan
    Senates, Ebubekir
    Eren, Fatih
    TUMORI JOURNAL, 2013, 99 (01): : 10 - 16
  • [2] The role of glucosylceramide and glucosylceramide synthase in liver disease: from bench to bedside
    Gan, Jian
    Zheng, Su Jun
    Mao, Xiao Rong
    Li, Jun Feng
    ACTA BIOCHIMICA POLONICA, 2021, 68 (01) : 33 - 39
  • [3] Organoids of liver diseases: From bench to bedside
    Wu, Li-Jun
    Chen, Zi-Yan
    Wang, Yi
    Zhao, Jun-Gang
    Xie, Xiao-Zai
    Chen, Gang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (16) : 1913 - 1927
  • [4] Role of platelets in chronic liver disease and acute liver injury
    Nowatari, Takeshi
    Murata, Soichiro
    Fukunaga, Kiyoshi
    Ohkohchi, Nobuhiro
    HEPATOLOGY RESEARCH, 2014, 44 (02) : 165 - 172
  • [5] Krabbe Disease: One Hundred Years From the Bedside to the Bench to the Bedside
    Wenger, David A.
    Rafi, Mohammad A.
    Luzi, Paola
    JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (11) : 982 - 989
  • [6] What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
    Danpanichkul, Pojsakorn
    Suparan, Kanokphong
    Kim, Donghee
    Wijarnpreecha, Karn
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [7] New insights in hepatocellular carcinoma: from bench to bedside
    De Minicis, Samuele
    Marzioni, Marco
    Benedetti, Antonio
    Svegliati-Baroni, Gianluca
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [8] Platelets in Non-alcoholic Fatty Liver Disease
    Dalbeni, Andrea
    Castelli, Marco
    Zoncape, Mirko
    Minuz, Pietro
    Sacerdoti, David
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside
    Aghemo, Alessio
    Colombo, Massimo
    SEMINARS IN IMMUNOPATHOLOGY, 2013, 35 (01) : 111 - 120
  • [10] Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside
    Alessio Aghemo
    Massimo Colombo
    Seminars in Immunopathology, 2013, 35 : 111 - 120